Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|February 6, 2019
Abrogation of Triazole Resistance upon Deletion of <i>CDR1</i> in a Clinical Isolate of <i>Candida auris</i>Jeffrey M Rybak, Laura A Doorley, Andrew T Nishimoto, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Analysis of clinical <i>Candida parapsilosis</i> isolates reveals copy number variation in key fluconazole resistance genesSean Bergin, Laura A Doorley, Jeffrey M Rybak, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 20, 2025
Relative contributions of the ERG11<sup>VF125AL</sup> and MRR1A<sup>N647T</sup> mutations to fluconazole resistance in Clade III Candidozyma (Candida) auris clinical isolatesKatherine S Barker, Qing Zhang, Tracy L Peters, et al.
Antimicrobial Agents and Chemotherapy|May 7, 2024
Analysis of clinical <i>Candida parapsilosis</i> isolates reveals copy number variation in key fluconazole resistance genesSean Bergin, Laura A Doorley, Jeffrey M Rybak, et al.
Mbio|April 4, 2019
Mutations in <i>hmg1</i>, Challenging the Paradigm of Clinical Triazole Resistance in Aspergillus fumigatusJeffrey M Rybak, Wenbo Ge, Nathan P Wiederhold, et al.
Pharmacotherapy|January 11, 2016
Pharmacokinetic and Pharmacodynamic Analyses of Ceftaroline in Adults with Cystic FibrosisElizabeth B Autry, Jeffrey M Rybak, Noelle R Leung, et al.
Antimicrobial Agents and Chemotherapy|August 18, 2025
Mutations in <i>TAC1B</i> drive increased <i>CDR1</i> and <i>MDR1</i> expression and azole resistance in <i>Candida auris</i>Katherine S Barker, Darian J Santana, Qing Zhang, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
A comparative evaluation of CRISPR-Cas9 allele editing systems in <i>Candida auris</i>: challenging research in a challenging bugDimitrios Sofras, Hans Carolus, Ana Subotić, et al.
Pageof 5